Phase II Study of Fludarabine + Idarubicin + Aracytine in Refractory or Relapsed ALL [acute lymphocytic leukaemia] in Children.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cytarabine; Fludarabine; Idarubicin
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 24 Sep 2012 Biomarkers information updated
- 10 Sep 2005 New trial record.